World Lung Day: impact of "the big 5 lung diseases" in the context of COVID-19.
作者信息
Cohen Mark, Levine Stephanie M, Zar Heather J
机构信息
Asociación Latinoamericana del Tórax, Hospital Centro Médico, Guatemala City, Guatemala.
Pulmonary Diseases and Critical Care Division, University of Texas Health Science Center at San Antonio, San Antonio, Texas.
出版信息
Am J Physiol Lung Cell Mol Physiol. 2022 Sep 1;323(3):L338-L340. doi: 10.1152/ajplung.00261.2022. Epub 2022 Aug 16.
Abstract
摘要
相似文献
1
World Lung Day: impact of "the big 5 lung diseases" in the context of COVID-19.世界肺病日：“五大肺病”在新冠疫情背景下的影响
Am J Physiol Lung Cell Mol Physiol. 2022 Sep 1;323(3):L338-L340. doi: 10.1152/ajplung.00261.2022. Epub 2022 Aug 16.
2
Social Disparities in Benign Lung Diseases.良性肺部疾病中的社会差异。
Thorac Surg Clin. 2022 Feb;32(1):43-49. doi: 10.1016/j.thorsurg.2021.09.006.
3
Impact of coronavirus disease-2019 on chronic respiratory disease in South Korea: an NHIS COVID-19 database cohort study.新型冠状病毒病 2019 对韩国慢性呼吸道疾病的影响：NHIS COVID-19 数据库队列研究。
BMC Pulm Med. 2021 Jan 6;21(1):12. doi: 10.1186/s12890-020-01387-1.
4
Towards regional progress: APSR 2022 Big Five Lung Diseases Workshop.迈向区域进展：亚太呼吸学会2022年五大肺部疾病研讨会
Respirology. 2023 Aug;28(8):807-816. doi: 10.1111/resp.14548. Epub 2023 Jul 11.
5
Obstructive lung diseases burden and COVID-19 in developing countries: a perspective.发展中国家的阻塞性肺疾病负担和 COVID-19：一个视角。
Curr Opin Pulm Med. 2022 Mar 1;28(2):84-92. doi: 10.1097/MCP.0000000000000836.
6
Advances in the relationship between periodontopathogens and respiratory diseases (Review).牙周病致病菌与呼吸系统疾病关系的研究进展（综述）。
Mol Med Rep. 2024 Mar;29(3). doi: 10.3892/mmr.2024.13166. Epub 2024 Jan 19.
7
Grape Phytochemicals and Vitamin D in the Alleviation of Lung Disorders.葡萄中的植物化学物质和维生素D对肺部疾病的缓解作用
Endocr Metab Immune Disord Drug Targets. 2022;22(13):1276-1292. doi: 10.2174/1871530322666220407002936.
8
The big 5 respiratory diseases give insight into respiratory health and beyond.五大呼吸道疾病有助于深入了解呼吸道健康及其他方面。
Respirology. 2023 May;28(5):496-497. doi: 10.1111/resp.14499. Epub 2023 Mar 29.
9
The global burden of respiratory disease-impact on child health.呼吸系统疾病的全球负担——对儿童健康的影响
Pediatr Pulmonol. 2014 May;49(5):430-4. doi: 10.1002/ppul.23030. Epub 2014 Mar 9.
10
The relationship between perioperative administration of inhaled corticosteroid and postoperative respiratory complications after pulmonary resection for non-small-cell lung cancer in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者非小细胞肺癌肺切除术后围手术期吸入性糖皮质激素的使用与术后呼吸并发症之间的关系
Gen Thorac Cardiovasc Surg. 2015 Dec;63(12):652-9. doi: 10.1007/s11748-015-0593-0. Epub 2015 Sep 29.
引用本文的文献
1
Bioprinted Four-Cell-Type Lung Model for Viral Infection Studies Under Air-Liquid Interface Conditions.用于气液界面条件下病毒感染研究的生物打印四细胞类型肺模型
Int J Mol Sci. 2025 Jun 10;26(12):5543. doi: 10.3390/ijms26125543.
2
A multidisciplinary approach towards modeling of a virtual human lung.一种针对虚拟人肺建模的多学科方法。
NPJ Syst Biol Appl. 2025 Apr 18;11(1):38. doi: 10.1038/s41540-025-00517-x.
3
Matrix-free human lung organoids derived from induced pluripotent stem cells to model lung injury.源自诱导多能干细胞的无基质人肺类器官用于模拟肺损伤。
Stem Cell Res Ther. 2024 Dec 18;15(1):468. doi: 10.1186/s13287-024-04106-3.
4
Hospitalisation patterns for respiratory diseases in Australia: an ecological study.澳大利亚呼吸系统疾病住院模式：一项生态学研究。
BMJ Open. 2024 Nov 27;14(11):e084286. doi: 10.1136/bmjopen-2024-084286.
5
Improving Computer-Aided Thoracic Disease Diagnosis through Comparative Analysis Using Chest X-ray Images Taken at Different Times.通过对不同时间拍摄的胸部 X 光图像进行比较分析，提高计算机辅助胸部疾病诊断水平。
Sensors (Basel). 2024 Feb 24;24(5):1478. doi: 10.3390/s24051478.
6
Task-shifting in asthma and chronic obstructive pulmonary disease management: A review of the obstructive lung disease program.哮喘和慢性阻塞性肺疾病管理中的任务转移：阻塞性肺病项目综述
Pak J Med Sci. 2024 Jan;40(2ICON Suppl):S42-S46. doi: 10.12669/pjms.40.2(ICON).8945.
7
The complement cascade in lung injury and disease.补体级联反应在肺损伤和疾病中的作用。
Respir Res. 2024 Jan 4;25(1):20. doi: 10.1186/s12931-023-02657-2.
本文引用的文献
1
Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries.改善中低收入国家获得负担得起的、有质量保证的吸入性药物的途径。
Int J Tuberc Lung Dis. 2022 Nov 1;26(11):1023-1032. doi: 10.5588/ijtld.22.0270.
2
Pathogenesis of chronic obstructive pulmonary disease: understanding the contributions of gene-environment interactions across the lifespan.慢性阻塞性肺疾病的发病机制：了解基因-环境相互作用在整个生命周期中的贡献。
Lancet Respir Med. 2022 May;10(5):512-524. doi: 10.1016/S2213-2600(21)00555-5. Epub 2022 Apr 12.
3
Higher coronavirus disease-19 mortality linked to comorbidities: A comparison between low-middle income and high-income countries.新型冠状病毒肺炎死亡率升高与合并症相关：低收入和中等收入国家与高收入国家的比较
J Educ Health Promot. 2021 Oct 29;10:377. doi: 10.4103/jehp.jehp_142_21. eCollection 2021.
4
Improving lung health in low-income and middle-income countries: from challenges to solutions.改善中低收入国家的肺部健康：从挑战到解决方案。
Lancet. 2021 Mar 6;397(10277):928-940. doi: 10.1016/S0140-6736(21)00458-X. Epub 2021 Feb 22.
5
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020：全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
6
Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.1990-2017 年慢性呼吸道疾病的流行情况和可归因健康负担：2017 年全球疾病负担研究的系统分析。
Lancet Respir Med. 2020 Jun;8(6):585-596. doi: 10.1016/S2213-2600(20)30105-3.
7
8
Ten principles for clean air.清洁空气的十条原则。
Eur Respir J. 2012 Mar;39(3):525-8. doi: 10.1183/09031936.00001112.
Zotero 插件